You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

Article info

Article menu

Download PDFPDF

Review
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

Authors

  • Xia Wang The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Shoujiang You Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Shoichiro Sato Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan PubMed articlesGoogle scholar articles
  • Jie Yang Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China PubMed articlesGoogle scholar articles
  • Cheryl Carcel The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Danni Zheng The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sohei Yoshimura The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan PubMed articlesGoogle scholar articles
  • Craig S Anderson The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia The George Institute China, Peking University Health Science Center, Beijing, China PubMed articlesGoogle scholar articles
  • Else Charlotte Sandset Department of Neurology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Thompson Robinson Department of Cardiovascular Sciences and NIHR Biomedical Research Unit for Cardiovascular Diseases, University of Leicester, Leicester, UK PubMed articlesGoogle scholar articles
  • John Chalmers The George Institute for Global Health, Newtown, New South Wales, Australia Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Vijay K Sharma Yong Loo Lin School of Medicine, National University of Singapore, Singapore Division of Neurology, National University Hospital, Singapore PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jie Yang; yangjie1126{at}163.com
View Full Text

Citation

Wang X, You S, Sato S, et al
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Stroke and Vascular Neurology 2018;3:doi: 10.1136/svn-2017-000112

Publication history

  • Received August 27, 2017
  • Revised November 17, 2017
  • Accepted November 20, 2017
  • First published January 13, 2018.
Online issue publication 
May 01, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/